Cargando…
Defining novel parameters for the optimal priming and expansion of minor histocompatibility antigen-specific T cells in culture
BACKGROUND: Adoptive transfer of minor histocompatibility antigen (MiHA)-specific T cells is a promising therapy for patients with hematological cancers. However, the efficacy of the transferred cells is hampered by the acquisition of terminal effector differentiation and exhaustion features during...
Autores principales: | Janelle, Valérie, Carli, Cédric, Taillefer, Julie, Orio, Julie, Delisle, Jean-Sébastien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4413989/ https://www.ncbi.nlm.nih.gov/pubmed/25925868 http://dx.doi.org/10.1186/s12967-015-0495-z |
Ejemplares similares
-
T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
por: Janelle, Valérie, et al.
Publicado: (2020) -
Thymic cytotoxic T lymphocytes are primed in vivo to minor histocompatibility antigens
Publicado: (1984) -
Minor Histocompatibility Antigen-Specific T Cells
por: Summers, Corinne, et al.
Publicado: (2020) -
Cellularly defined minor histocompatibility antigens are differentially expressed on human hematopoietic progenitor cells
Publicado: (1988) -
Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8(+) antigen-specific T cells for adoptive immunotherapy
por: Lak, Shirin, et al.
Publicado: (2022)